FDA official says Zoetis, Eli Lilly support antibiotic strategy
(Reuters) - Animal health companies Zoetis Inc and Eli Lilly & Co support the U.S. Food and Drug Administration's new voluntary phase-out of antibiotic use in animal production, the agency said during a conference call with reporters.
Deputy Commissioner for foods and veterinary medicine Michael Taylor said he expects animal health companies to readily comply with the FDA strategy. Otherwise, he said the FDA would be able to take regulatory action.
"Zoetis and Elanco (Lilly) have already declared their support to remove these production uses from their products," Taylor said.
(Reporting by Caroline Humer; Editing by Gerald E. McCormick)
- South Korea investigates capsized ferry crew, stowage as rescue hampered |
- After Nevada ranch stand-off, emboldened militias ask: where next?
- Retailer Michaels Stores confirms payment card data breach
- All 338 Korean students, teachers rescued from sinking ferry - school official
- Nobel winner Garcia Marquez, master of magical realism, dies at 87 |